Related Experiment Video
Updated: Jul 11, 2026

Repeated Measurement of Respiratory Muscle Activity and Ventilation in Mouse Models of Neuromuscular Disease
Published on: April 17, 2017
[Ventilatory dysfunction in motor neuron disease: when and how to act?]
1Serviço de Fisiatria, Hospital Senhora da Oliveira, Guimarães.
Abstract:
Amyotrophic lateral sclerosis is a devastating progressive neurodegenerative disorder, involving motor neurons in the cerebral cortex, brainstem and spinal cord. Mean duration of survival from the time of diagnosis is around 15 months, being pulmonary complications and respiratory failure responsible for more than 85% of deaths. Albeit the inevitability of respiratory failure and short-term death, standardized intervention protocols have been shown to significantly delay the need for invasive ventilatory support, thus prolonging survival and enhancing quality of life. The authors present an intervention protocol based on clinical progression and respiratory parameters. Decisions regarding initiation of non-invasive positive pressure ventilation (NIPPV) and mechanically assisted coughing, depend on development of symptoms of hypoventilation and on objective deterioration of respiratory parameters especially in what concerns bulbar muscle function. These include maximum inspiratory capacity (MIC), difference between MIC and vital capacity (MIC-VC), and assisted peak cough flow (PCF). These standardized protocols along with patient and caregivers education, allow for improved quality of life, prolonged survival and delay or eventually prevent the need for tracheotomy and invasive ventilatory support. Supplemental oxygen should be avoided in these patients, since it precludes use of oxymetry as feedback for titrating NIPPV and MAC, and is associated with decreased ventilatory drive and aggravated hypercapnia.
Insights
Standardized protocols for managing respiratory issues in amyotrophic lateral sclerosis (ALS) significantly improve survival and quality of life. These protocols guide interventions like non-invasive positive pressure ventilation (NIPPV) and mechanically assisted coughing (MAC).
Area of Science:
- Neurology
- Pulmonology
- Respiratory Medicine
Context:
- Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease affecting motor neurons.
- Respiratory failure and pulmonary complications cause over 85% of deaths in ALS patients.
- Survival is typically around 15 months post-diagnosis.
Purpose:
- To present a standardized intervention protocol for managing respiratory decline in ALS.
- To guide decisions on initiating non-invasive positive pressure ventilation (NIPPV) and mechanically assisted coughing (MAC).
Summary:
- The protocol utilizes clinical progression and respiratory parameters, including maximum inspiratory capacity (MIC), MIC-VC, and assisted peak cough flow (PCF).
- Initiation of NIPPV and MAC is based on hypoventilation symptoms and objective respiratory parameter deterioration, particularly bulbar muscle function.
- Patient and caregiver education is integral to the protocol.
Impact:
- Standardized protocols prolong survival and enhance quality of life for ALS patients.
- These interventions delay or prevent the need for tracheotomy and invasive ventilatory support.
- Avoidance of supplemental oxygen is recommended to maintain optimal NIPPV and MAC titration and prevent hypercapnia.
Related Concept Videos
Mechanical Ventilation I: Indication and Settings
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Acute Respiratory Failure-III
Mechanical Ventilation II: Invasive Ventilation
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Skeletal Muscle Relaxants: Therapeutic Uses
